Special treatment of patients suffering from a mixed copulatory dysfunction with interoreceptive syndrome
Izbasarov A.I., Ismoldaev E.S., Khusainov T.E.
3rd Urology Congress of Khazakhstan May 25-26, 2000, Almaty
Full text in Russian, Czech abstract
A total of 38 patients suffering from a mixed copulatory dysfunction were recruited into the trial. Twelwe of them were at the age ranging from 20 up to 30 years, fourteen at the age from 31 to 40 years, eight at the age from 41 to 50 years and four at the age from 51 to 60 years. Microbiological investigation of a prostate secreta revealed following microbial agents: E.coli in 14 patients (36,8%), Trich. vaginalis in 10 patients (26,3%), Staph. aureus in 5 patients (13,2%), Str.faecalis in 4 patients (10,6%), Proteus in 3 patients (7,8%) and Klebsiella in 2 patients (5,3%). An impaired copulatory function was observed. Libido was reduced in 8 patients, erection was impaired in 38 patients (100%), ejaculation was impaired in 12 patients (31,6%). At the first stage of the treatment, antibiotics were administered according to the results of the investigation of a microbial agents susceptibility. In order to minimize the ts of antibiotic side effects, a combination enzyme preparation Wobenzym was included into the treatment. Its antiflogistic and immunomodulatory effects have been reported (Repina A.M., 1997). The patients were divided into two groups, each consisting of 19. The first group was treated with antibiotic ( and in some cases antiprotozoic ) drugs in combination with Wobenzym in doses 3 - 5 tablets three times a day 30 - 40 minutes before meals for 2 - 3 weeks. The second one group was treated without Wobenzym. The treatment was more succesful in the enzyme group ( 89,5% of recovery) in comparison to the control one ( 68,4% of recovery). The second stage of the treatment was concerned in a removal of psychogenic syndrome by means of psychotherapy and psychotropic drugs. In summary the libido increased in all 38 (100%) patients, erection was improved in 32 (84,2%) patients and a positive therapeutic effect was achieved in 29 (75%) patients suffering from the impaired erection.